Previous 10 | Next 10 |
Image source: The Motley Fool. CASI Pharmaceuticals Inc (NASDAQ: CASI) Q4 2019 Earnings Call Mar 16, 2020 , 4:30 p.m. ET Operator Continue reading
CASI Pharmaceuticals (NASDAQ: CASI ): FY GAAP EPS of -$0.48 misses by $0.07 . More news on: CASI Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
ROCKVILLE, Md. and BEIJING , March 16, 2020 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today reported financial results for the year ended...
Deals and Financings Alphamab Oncology, a company developing eight bispecifics for oncology, plans to stage an IPO before the end of the year on the Hong Kong Exchange that could raise up to $350 million. Alphamab Oncology is a spin out from Suzhou Alphamab. The company plans to use the proc...
The China National Medical Product Administration (NMPA) has approved CASI Pharmaceuticals' (NASDAQ: CASI ) clinical trial applications for CNCT19 (CD19 CAR-T) in relapsed/refractory B-cell acute lymphoblastic leukemia (B-ALL) and B-cell non-Hodgkin lymphoma (B-NHL) submitted by its p...
ROCKVILLE, Md. and BEIJING , Dec. 3, 2019 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, announces that the China National Medical Product Adm...
CASI Pharmaceuticals (NASDAQ: CASI ): Q3 GAAP EPS of -$0.10 beats by $0.01 . More news on: CASI Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
ROCKVILLE, Md. and BEIJING , Nov. 12, 2019 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing therapeutics and pharmaceutical products, today reported financial results for the third quarter and nine m...
ROCKVILLE, Md. and BEIJING , Nov. 7, 2019 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, announces an exclusive distribution agreement with Ph...
Deals and Financings China Biologic Products (CBPO), a blood products company, received a $4.6 billion takeover offer from a group of six investment firms (see story ). The proposal was priced at $120 per share, a 16% premium to the previous close. CBPO operates plasma-gathering facilities ...
News, Short Squeeze, Breakout and More Instantly...
CASI Pharmaceuticals Inc. Company Name:
CASI Stock Symbol:
NASDAQ Market:
CASI Pharmaceuticals Inc. Website:
2024-07-17 13:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
CASI Pharmaceuticals announces appointment of Daniel Lang, MD as CFO and SVP PR Newswire BEIJING , July 8, 2024 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a Cayman incorporated biopharmaceutical company focused on developing and commercializing in...
A look at the top 10 most actives in the United States Faraday Future Intelligent Electric Inc. (FFIE) rose 30.9% to $0.6 on volume of 558,931,853 shares NVIDIA Corporation (NVDA) fell 1.9% to $123.99 on volume of 249,243,816 shares Assure Holdings Corp. (IONM) rose 82.8% to $0.424 on vol...